Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment

Cellular immunotherapy is becoming a new pillar in cancer treatment after recent striking results in different clinical trials with chimeric antigen receptor T cells. However, this innovative therapy is not exempt from challenges such as off-tumor toxicity, tumor recurrence in heterogeneous tumors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Motais, Benjamin, Charvátová, Sandra, Walek, Zuzana, Hrdinka, Matouš, Smolarczyk, Ryszard, Cichoń, Tomasz, Czapla, Justyna, Giebel, Sebastian, Šimíček, Michal, Jelínek, Tomáš, Ševčíková, Tereza, Sobotka, Jiří, Kořístek, Zdeněk, Hájek, Roman, Bagó, Juli R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143171/
https://www.ncbi.nlm.nih.gov/pubmed/33919155
http://dx.doi.org/10.3390/cells10050967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143171/
https://www.ncbi.nlm.nih.gov/pubmed/33919155
http://dx.doi.org/10.3390/cells10050967

Ejemplares similares